Showing results (291-300 of 310) with videos related to
Sort By:
Pageof 31
American Journal of Respiratory Cell and Molecular Biology|February 8, 2017
Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta-analysis of 16,707 SubjectsRobert Busch, Brian D Hobbs, Jin Zhou, et al.Respiratory Medicine|January 7, 2023
COPD: Providing the right treatment for the right patient at the right timeAlvar Agusti, Nicolino Ambrosino, Felicity Blackstock, et al.Human Molecular Genetics|July 31, 2018
Whole exome sequencing analysis in severe chronic obstructive pulmonary diseaseDandi Qiao, Asher Ameli, Dmitry Prokopenko, et al.Lancet (London, England)|February 25, 2021
Improving lung health in low-income and middle-income countries: from challenges to solutionsJamilah Meghji, Kevin Mortimer, Alvar Agusti, et al.American Journal of Respiratory and Critical Care Medicine|October 7, 2025
Maternal Smoking and CC-16: Implications for Lung Development and COPD Across the LifespanJoselyn Rojas-Quintero, Rosa Faner, Chia-Ying Chiu, et al.American Journal of Respiratory and Critical Care Medicine|August 17, 2013
Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary diseaseDonavan T Cheng, Deog Kyeom Kim, Debra A Cockayne, et al.Trials|April 15, 2022
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)Seonaidh Cotton, Graham Devereux, Hassan Abbas, et al.ERJ Open Research|September 23, 2020
Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocolAlexander G Mathioudakis, Fekri Abroug, Alvar Agusti, et al.Current Pharmaceutical Design|March 20, 2014
A systems medicine clinical platform for understanding and managing non- communicable diseasesAlfredo Cesario, Charles Auffray, Alvar Agusti, et al.The European Respiratory Journal|October 15, 2021
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbationsAlexander G Mathioudakis, Fekri Abroug, Alvar Agusti, et al.Pageof 31